Prognostic Factors in Acute Myeloid Leukemia
Author Information
Author(s): L. Skoog, A. Ost0, P. Biberfeld, B. Christensson, R. Hast, B. Lagerldfl, B. Nordenskjold, P. Reizenstein
Primary Institution: Karolinska sjukhuset
Hypothesis
Can terminal transferase activity and glucocorticoid receptor levels predict prognosis in acute myeloid leukemia?
Conclusion
Combined measurements of terminal transferase and glucocorticoid receptor levels are useful predictors of prognosis in acute myeloid leukemia.
Supporting Evidence
- Patients with detectable levels of TdT had a higher complete remission rate.
- Younger patients with increased TdT activity had longer survival.
- High glucocorticoid receptor levels were positively correlated with remission rates.
- Patients with both high TdT and glucocorticoid receptor levels had significantly higher remission and survival rates.
Takeaway
Doctors can use two specific tests to help figure out how well a patient with a type of blood cancer called acute myeloid leukemia might do.
Methodology
A retrospective study evaluating terminal transferase activity and glucocorticoid receptor levels in 52 adult patients with acute myeloid leukemia.
Limitations
The study only included adult patients and may not be applicable to other age groups.
Participant Demographics
52 adult patients, with 30 under 60 years and 22 over 60 years.
Statistical Information
P-Value
0.001
Statistical Significance
p=0.001
Want to read the original?
Access the complete publication on the publisher's website